Enterprise of Rosatom State Corporation
Print version
Main | Company news

Company news

06/09/2021

Isotope JSC experts participated in the oncological conference in Italy

On September, 2-4 representatives of Isotope JSC took part in the second Russian-Italian scientific conference "Challenges of oncology in the era of COVID-19 ", held in a hybrid format in Taranto (Italy). The conference was organized by «Group of Oncologists from Southern Italy» (Gruppo oncologico dell 'Italia Meridionale). Among the conference participants were representatives of state institutions of the Apulia region, members of the oncological community in Italy and Russia, university rectors and other healthcare experts.

As part of the online session of the conference "Atomic Technologies and Science: Together against Oncology. Advanced radiopharmaceuticals", organized with the support of JSC Isotope, speakers presented presentations on current topics and challenges in the use of radiopharmaceuticals, global trends in the development of radiopharmaceuticals and successful clinical practices. In the discussion, the participants of the event discussed modern approaches to the treatment of various diseases using radionuclide diagnostics and therapy. Particular attention was paid to the use of promising radiopharmaceuticals based on lutetium-177 and radium-223.

It should be noticed that Isotope JSC has been developing a partnership with the Italian side since 2019 within the framework of the Memorandum of Understanding. It was signed in order to develop and strengthen cooperation in the field of healthcare, therapeutic radiology in oncology and nuclear medicine in the Russian Federation and Apulia region (Republic of Italy).


comments powered by Disqus